Trading Summary - December 23. A satisfactory status quo

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
189
Trading Summary - December 23.

A satisfactory status quo day for $SFLM while OTC market top traders who already have the shares they need at current price levels under .0052 needed to be elsewhere on other Watch List movers - primarily $IJJP, $PSRU and $INQD.

At the open, MMs clearly indicated they were willing to let $SFLM run - asks were cancelled at .0018, .0019 and some of the .0020 leaving just 1.5M. When traders failed to hit the ask aggressively enough, the usual games observed ensued.

If we don't see an end to the nonsense next week, you can expect top traders to start hitting the ask to get a move on and shorters to retreat once we are in the nex tax year.

Overall, another 5.4M shares were bought today at bottom prices in the same broad range .0016 > .0052 as makes little difference at .01 > .02+. As predicted, top long term traders are more likely to buy 1M+ at each price point at current levels rather than 100K > 200K - and were seen to do so.

Since the loading at bottom prices total was restarted after the last run, 767.1M shares have been bought up to .0052 in 65 trading days September 22 - December 23 - 91.6% of the low Unrestricted Outstanding Shares count.

New interest traders / alerters + long-term traders with significant followings as at December 19 numbered at least 138 - up another 6 in the previous 7 days. List here:

https://investorshangout.com/post/view?id=6304978

Particular points they like are:

- Real revenue of $10M+ per year.

- Operating profit achieved in Q3.

- $49K in cash available for inventory purchases.

- Assets of $1.398M.

- Low Unrestricted O/S of 837M - with none added in the last 3+ months.

- How thin it is into the .01 > .02 range.

On the next run over .01, the degree to which $SFLM penetrates up towards .02+ will depend on how many of these new followers take profits above .01.

Either way, longs who follow my strategy will be keeping their core holding for the OTCQB uplisting - which will require sustaining prices above a .01 bid - and also some for when all 9 elements reach the same revenue level anticipated by the CEO. Trading some on every surge allows a larger core to be held on a cost basis that is essentially "free" - already paid for by banked profits.

The correct market cap price for the anticipated revenue as income ramps up under the Collectibles Marketplace Strategy would be in the .062 > .1075 range in future years when they manage to get all 9 elements in the plan to the performance level of the existing SFLMaven eBay business (plus remember more platforms coming as well).

On $SFLM, the larger the inventory of shares acquired below .0050, the more that will be available to trade for 100% to 400% in the .01 > .0150 range on the next run to that level - whenever that may be - whilst also retaining a significant core converted to free for OTCQB uplisting and the planned 8 x 2021 revenue under the Collectibles Marketplace Strategy.

Remember that the price difference between .0020 and .0050 is irrelevant when traded at .01 > .02+ - let alone at .062 > .1075.

Every 1M bought at .0050 is worth a $7K profit at .0120, $10K profit at .0150, $15K profit at .02, $57K profit at .074 or $ 102.5K profit at .1075.

All that matters is who got where - charts are irrelevant - and denying as many shares under .01 as possible to the institutional level new interest that PRs + improving financials + MZ Group though investor symposiums are expected to bring in over the days, weeks and months ahead in 2022.

Latest DD - updated December 19 - here:

https://investorshangout.com/post/view?id=6304993

The anticipated revenue in 2021 - based on pro-rata of sales to date - is $10M+.

Additional inventory on the 1stDibs store at "BuyItNow" prices total of $331K.

$SFLM remains my #1 Top Profit Pick for the whole of 2021 and for me is currently #1.

It will now also be the #1 or #2 Top Profit Pick for the whole of 2022 (depending on $ENZC developments in the next few months).

I will not necessarily be doing a trading summary every day - unless there are undue manipulation attempts - as the ticker is firmly under control and just awaiting the next run into the .01 > .02 range.

iHub has been deliberated marginalized due to time-wasting nonsense there with all serious interest successfully directed to here over the last several months - with typically 500 > 700+ views per day - and repeated where interest in "real" companies is known to exist.

2021 Q3 Key Points here:

https://investorshangout.com/post/view?id=6283945

Watch for the next PR which I would expect to cover the excellent Q3 results, the sales since in October and November, and any developments from the CEO attending a NFT / crypto expo in Miama.

The Share Structure was updated after the close on December 7 - again showing no change and confirming no dilution for the 3rd month - with the Unrestricted O/S remaining at a low 837M.

Watch for the next auction tonight. If we don't get an update from the company tomorrow, I will add up manually from eBay over the weekend.

I will also update the trader interest list and master DD over the weekend.

Happy Christmas - excited for $SFLM in 2022 !

SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Agroz's Big Leap: New Supply Deal in Malaysia

Updated Category News Views 3

Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...

Continue Reading
RARE Foundation Rebrands, Focus Still Strong

Updated Category News Views 3

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Continue Reading
Cove Capital Secures $9.96M for Debt-Free Logistics DST

Updated Category News Views 3

Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 5

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 3

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading
Midlife ADHD in Women: New Challenges and Solutions

Updated Category News Views 5

ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...

Continue Reading
Tampa General’s Innovation Excellence Earns No. 20 Spot

Updated Category News Views 7

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...

Continue Reading
Give Lively & Change Simplify CA Nonprofit Compliance

Updated Category News Views 1

A Fresh Wind Blowing for California Nonprofits So, here's a twist in the nonprofit world that's stirring the pot just right. Give Lively and Change have partnered up to tackle the thorny issue of regulatory compliance in California. It's a big win for the nonprofits looking to keep fundraising through Give Lively without getting tangled in the bureaucratic web spun up by...

Continue Reading
Veho's Role in Redefining Beauty E-Commerce Delivery

Updated Category News Views 2

Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...

Continue Reading
RevSystems Joins Elite OpenAI Partner Network

Updated Category News Views 3

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Continue Reading

Top 5 Most Recently Viewed Articles

Natural Diamonds Resilient Amid Market Shifts and Trends

Updated Category News Views 679

The Strength of Natural Diamonds in Today's Market As we enter a new year, the natural diamond market has shown a robust performance, providing encouraging signs of stability, strength, and growth. Jewelers have reported solid year-end results, showcasing steady or improved sales levels compared to previous periods. This positive trend reinforces the perception of natural...

Continue Reading
Bicara Therapeutics' Plans for Public Offering Showcase Growth

Updated Category News Views 183

Overview of Bicara Therapeutics' Initial Public Offering Bicara Therapeutics Inc. (NASDAQ: BCAX), an innovative biopharmaceutical company currently in the clinical stage, has just taken an exciting step forward. They've announced the pricing for their initial public offering (IPO), which includes 17,500,000 shares of common stock, each priced at a competitive $18.00. This...

Continue Reading
Class Action Alert for Semtech Corporation Investors

Updated Category News Views 107

Legal Update for Semtech Corporation Shareholders The Gross Law Firm has released an important notice specifically for shareholders of Semtech Corporation (NASDAQ: SMTC). This notice comes in light of a class action lawsuit that has been filed, and it outlines essential details regarding the lawsuit and actions that shareholders can take to safeguard their rights....

Continue Reading
Critical Insights on the Beyond Meat Securities Investigation

Updated Category News Views 241

Understanding the Investigation into Beyond Meat Beyond Meat, Inc. (NASDAQ: BYND), renowned for its innovative plant-based meat alternatives, is currently under scrutiny regarding potential violations of federal securities laws. This investigation, announced by a leading securities law firm, raises concerns for investors who may have suffered losses due to possible...

Continue Reading
Immunic Navigates Investor Events As Trials Advance

Updated Category News Views 2

Braving the Investor Circuit Immunic's ready to make some moves this July—this crew's diving headfirst into a trio of investor conferences. They're not just chitchatting; they’re taking one-on-one meetings, holding fireside chats. What’s the big draw? Their brainchild, vidofludimus calcium (IMU-838), which is knee-deep in phase 3 trials for relapsing multiple...

Continue Reading